How on earth was there a pump mate? No one knew this LCD was coming, the company raised to deliver growth and they did achieve that growth, with the 74% figure released the other day. So the reaction was completely justified, everything that was anticipated was delivered until the idiotic MACs decided to propose the LCD because iTrack was too popular. Unfortunately this LCD has come along and has put that growth on pause, but it certainly wont last forever, and it only impacts a minority of customers (only a small percentage of Americans have public insurance), so soon enough they'll be back to achieving those high growth figures they recorded immediately after the launch. Enough with the rubbish "management giving cheap shares to mates" conspiracy theories, these guys aren't the type (just compare their compensation to most companies - they're clearly not bleeding shareholders to fill their pockets or the pockets of their mates). Massive overreaction to what will likely end up being merely a speed bump.
- Forums
- ASX - By Stock
- EYE
- Ann: Update on Proposed USA Medicare Changes
Ann: Update on Proposed USA Medicare Changes, page-31
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.64M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 15.5¢ | $65.26K | 412.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 76733 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 239407 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 76733 | 0.155 |
5 | 139500 | 0.150 |
9 | 619724 | 0.145 |
11 | 450030 | 0.140 |
2 | 14500 | 0.135 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 239407 | 5 |
0.165 | 100000 | 1 |
0.170 | 200000 | 3 |
0.175 | 100000 | 1 |
0.180 | 100000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online